Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
C1q inhibits immune complex-induced interferon-[alpha] production in plasmacytoid dendritic cells: A novel link between C1q deficiency and systemic lupus erythematosus pathogenesis
Arthritis & Rheumatism, 10/05/09
Lood C et al. – The findings contribute to the understanding of why C1q deficiency is such a strong risk factor for SLE and suggest an explanation for the up–regulation of the type I IFN system seen in SLE patients.
Christian Lood, 10/08/09
| C1q deficiency has since many years been associated with development of SLE and the major hypothesis for this association is decreased clearance of apoptotic cells. However, recent published data from our group (Gullstrand et al 2009) demonstrated that there could be alternative explainations for the strong association between C1q deficiency and SLE. Here, we could demonstrate a novel function of C1q in the regulation of immune complex-induced interferon-alpha production by plasmacytoid dendritic cells. These findings are important for the understanding of the role of C1q in protection against development of lupus, and may also be important when exploring new therapeutic strategies aiming to down-regulate the activated plasmacytoid dendritic cells in SLE patients |
Related Articles
Ten cases of systemic lupus erythematosus related to hepatitis B vaccine
Lupus, 11/09/09
Relevance Score: 71%
Safety of vaccination of patients with systemic lupus erythematosus
Lupus, 11/04/09
Relevance Score: 70%
Infection—genetics relationship in systemic lupus erythematosus
Lupus, 11/05/09
Relevance Score: 69%
Developments in the clinical understanding of lupus
Arthritis Research & Therapy, 10/29/09
Relevance Score: 69%
Simultaneous herpes simplex virus esophagitis and lupus enteritis in a patient with systemic lupus erythematosus
Modern Rheumatology, 10/23/09
Relevance Score: 69%
Today in Rheumatic/Autoimmune...keeping you current
Receive free subspecialty "5-minute updates" via email
Update in treatment options for psoriatic arthritis
Expert Review of Clinical Immunology, 11/23/09
Adalimumab for the treatment of psoriatic arthritis
Expert Review of Clinical Immunology, 11/19/09
Functional activation of proline-rich tyrosine kinase2 (PYK2) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus
BMC Musculoskeletal Disorders, 11/18/09
Sponsor
Article Search
Sponsor


See Latest Articles


